Evidence map›Paper›PMID 36755852›Full record

ArticleFrontiers in cellular and infection microbiology2022

Case Report:

Changquan Fang, Limin Xu, Jiarong Tan, Hongyi Tan, Junhong Lin, Ziwen Zhao

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Clinical utility of metagenomic next-generation sequencing in diagnosing spinal infections: a systematic review and meta-analysis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
  2. Article
  3. Clinical management and pharmaceutical care of severeFrontiers in cellular and infection microbiology · 2026
    Review
  4. Article
  5. Omadacycline for the Treatment of SevereInfection and drug resistance · 2024
    Article
  6. Infection and drug resistance · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Changquan FangDepartment of Pulmonary and Critical Care Medicine, Huizhou Central People's Hospital, Huizhou, Guangdong, China.
Limin XuDepartment of Geriatrics, Huizhou First People's Hospital, Huizhou, Guangdong, China.
Jiarong TanDepartment of Pulmonary and Critical Care Medicine, Huizhou Central People's Hospital, Huizhou, Guangdong, China.
Hongyi TanDepartment of Pulmonary and Critical Care Medicine, Huizhou Central People's Hospital, Huizhou, Guangdong, China.
Junhong LinDepartment of Pulmonary and Critical Care Medicine, Huizhou Central People's Hospital, Huizhou, Guangdong, China.
Ziwen ZhaoDepartment of Pulmonary and Critical Care Medicine, Guangzhou First People's Hospital Affiliated to South China University of Technology, Guangzhou, Guangdong, China.
Huizhou Central People's Hospital · CNGuangzhou First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psittacosis and Guillain-Barré syndrome are both rare clinical diseases with low incidence, and their combination has rarely been reported. Here, we report a case of

Indexed as

Chlamydophila psittaciGuillain-Barre SyndromePneumoniaPsittacosisAnti-Bacterial AgentsFatigueHigh-Throughput Nucleotide SequencingHumansAnti-Bacterial Agentsantibiotic therapychlamydia psittaci pneumoniaGuillain-Barre syndromemetagenomic next-generation sequencingpsittacosis

Identifiers

PMID36755852
PMCPMC9901563
OpenAlexW4317722107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.